Sato, T. (2021) “Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19”, Journal of Pharmacy & Pharmaceutical Sciences, 24, pp. 227–236. doi: 10.18433/jpps31813.